In this study, suppression of PARP1 activation alleviates cholesterol accumulation by facilitating cholesterol disposal, indicating that PARP1-induced impairment of LXRα sensing is an important mechanism underlying liver cholesterol metabolic disorders, including NASH 20. Here, PARP1 is linked to medical procedure.